Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Z Gastroenterol ; 53(3): 199-204, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25775169

ABSTRACT

BACKGROUND: The balanced activity of matrix metalloproteinases and their tissue inhibitors is an important, albeit still not completely understood, determinant of extracellular matrix homeostasis, a factor involved in the pathogenesis of acute pancreatitis (AP). AIMS: The aim of this study was to compare serum concentrations of matrix metalloproteinase 9 (MMP-9) and its tissue inhibitor (TIMP-1) in patients with AP of various severity and to investigate their relationship with prognostic indicators of AP severity, e.g., polymorphonuclear leukocyte elastase (PMN-E). PATIENTS AND METHODS: The study included 37 patients with mild (n = 18) or severe AP (n = 19) and 15 healthy controls. Serum concentrations of MMP-9 and TIMP-1 were determined on admission (day 1) and on days 2, 3, 5 and 10. RESULTS: Throughout the study period, the serum MMP-9 concentration in patients with severe AP was significantly higher than those in individuals with mild AP and in healthy controls. In turn, the serum MMP-9 concentrations in persons with mild AP did not differ significantly from those of the controls. The serum TIMP-1 concentrations in both groups were significantly higher than in the controls. Beginning from the 2(nd) day of hospital stay, the serum TIMP-1 concentration in patients with severe AP was significantly higher than in individuals with mild AP. There were significant correlations between: MMP-9 and PMN-E, TIMP-1 and PMN-E, and MMP-9 and TIMP-1. CONCLUSION: A disturbed balance between MMP-9 and TIMP-1 observed during the early stages of severe AP suggests that endogenous TIMP-1 is unable to prevent excessive activation and release of MMP-9. MMP-9 may represent a new marker of AP severity.


Subject(s)
Matrix Metalloproteinase 9/blood , Pancreatitis/diagnosis , Pancreatitis/metabolism , Tissue Inhibitor of Metalloproteinase-1/blood , Acute Disease , Adult , Aged , Aged, 80 and over , Biomarkers/blood , Female , Humans , Male , Middle Aged , Reproducibility of Results , Sensitivity and Specificity , Severity of Illness Index
2.
Pancreas ; 26(2): 144-52, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12604912

ABSTRACT

INTRODUCTION: Excessive inflammatory response is one of the major causes of early mortality in acute pancreatitis (AP). AIM: To evaluate the serum profiles of E-selectin, interleukin (IL)-6, and IL-10 along with their correlation to the markers of oxidative stress and neutrophil activation in patients with AP and patients with nonpancreatic acute abdominal pain (NPAAP). METHODOLOGY: This prospective clinical study included 56 patients with AP (28 with mild AP and 28 with severe AP) as well as 15 patients with NPAAP. RESULTS: Serum concentrations of E-selectin, IL-10, and IL-6 and plasma concentrations of polymorphonuclear leukocyte elastase (determined on days 1-3, 5, and 10 after admission) were the highest in severe AP during the first 3 days and then declined. At day 10, the E-selectin level in severe AP was still higher than that in mild AP, and the IL-10 concentration increased again. There was no elevation in the E-selectin concentration in NPAAP patients, and IL-10 levels remained unchanged in mild AP. Oxidative stress, measured by serum malondialdehyde and 4-hydroxyalkenals levels, was the most pronounced in severe AP. CONCLUSIONS: The serum E-selectin concentration is markedly elevated in severe AP and is less in mild AP but not in NPAAP. It may result from stimulation with different inflammatory mediators or indicate vascular endothelium injury mediated by oxidative stress, especially in the severe form of AP.


Subject(s)
Abdominal Pain/blood , Biomarkers/blood , Oxidative Stress , Pancreatitis/blood , Acute Disease , Adult , Aged , Aged, 80 and over , Aldehydes/blood , E-Selectin/blood , Female , Humans , Interleukin-10/blood , Interleukin-6/blood , Leukocyte Elastase/blood , Male , Malondialdehyde/blood , Middle Aged , Statistics as Topic
3.
Scand J Gastroenterol ; 37(9): 1097-102, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12374236

ABSTRACT

BACKGROUND: Interleukin 18 (IL-18) is a new mediator and modulator of the immune response; its role in acute pancreatitis (AP), however, has not yet been fully explained. The aim of our study was to evaluate the profile IL-18 serum concentrations in the course of acute pancreatitis. METHODS: The prospective study involves 30 patients with AP (n = 15 with mild AP and n = 15 with severe AP) as well as 10 healthy subjects. AP severity was defined according to Ranson's and Balthazar's criteria, supplemented by serum CRP concentration measurements. In the course of hospitalization, 2 patients with severe AP died. Serum IL-18 and plasma polymorphonuclear leukocyte elastase (PMN-E) concentrations were measured at admission (day 1) and on days 2, 3, 5 and 10. RESULTS: In both the mild and the severe forms of AP, serum IL-18 concentration was significantly higher than in the healthy controls. In severe AP, serum IL-18 reached the highest levels in all observed periods compared to that in patients with mild AP. Significant correlations, calculated for day 1, were found between serum IL-18 and plasma PMN-E (Rs = 0.514. P < 0.001) and between IL-18 and CRP (Rs = 0.463, P < 0.001) levels. CONCLUSIONS: Serum profile IL-18 during AP indicates that this cytokine was released early after AP onset and may play the key role in inflammatory and immune response. Positive correlation between serum IL-18 and commonly known early prognostic markers of AP severity suggest that serum IL-18 concentrations may represent another early marker indicating severe course of AP.


Subject(s)
Interleukin-18/blood , Pancreatitis/blood , Acute Disease , Adult , Aged , Aged, 80 and over , C-Reactive Protein/analysis , Female , Humans , Leukocyte Elastase/blood , Male , Middle Aged , Neutrophil Activation , Pancreatitis/classification , Prognosis , Prospective Studies
4.
Arch Immunol Ther Exp (Warsz) ; 49(4): 317-24, 2001.
Article in English | MEDLINE | ID: mdl-11726035

ABSTRACT

Severe trauma acts as a trigger for the complex cascade of postinjury events leading to the release of different mediators and the development of generalized inflammation. Selectins are a family of adhesion proteins that are responsible for the adherence of polymorphonuclear neutrophils to the endothelium. This interaction plays an important role in the development of severe complications after multiple trauma. The aim of the present study is to follow the sequential alterations in circulating selectin levels after severe injury and to evaluate the clinical significance of these mediators in monitoring prognosis and outcome. Thirty four severely traumatized patients were entered into the study. Serum sE-selectin, plasma sP-selectin and sL-selectin concentrations were measured and an APACHE II score was calculated on admission to the intensive care unit and during the subsequent 5 days. The patients were divided into survivors and nonsurvivors. Initial soluble P- and E-selectin concentrations were significantly elevated in all trauma patients. The highest values of these adhesion molecules were measured in all the observed days in patients with poor prognosis and outcome. In survivors we found a systematic decrease in the sP-selectin concentrations. On admission, the sL-selectin concentrations in all trauma patients were decreased. There were stable, very low values in nonsurvivors and a slow increase in circulating L-selectin in patients who survived. The pattern of soluble selectins in patients with severe trauma is characterized by increased levels of P- and E-selectin and a decreased concentration of L-selectin. These findings suggest a widespread microvascular endothelial activation on injury in the early posttraumatic period, which may be associated with increased neutrophil-endothelial adhesion, neutrophil extravasation and migration. We suppose that these parameters of endothelial cell activation/injury may be useful as another early prognostic factor in severe trauma.


Subject(s)
Selectins/blood , Wounds and Injuries/blood , Adult , Aged , Cell Adhesion , E-Selectin/blood , Endothelium, Vascular/injuries , Endothelium, Vascular/physiopathology , Female , Humans , L-Selectin/blood , Male , Middle Aged , Neutrophils/physiology , P-Selectin/blood , Prognosis , Solubility , Wounds and Injuries/physiopathology
5.
Przegl Lek ; 58(7-8): 767-71, 2001.
Article in Polish | MEDLINE | ID: mdl-11769384

ABSTRACT

The pulmonary endothelium synthesizes many bioactive compounds and their activation or injury may cause release these substances into the blood. We determined the influence of trauma severity for endothelium activation/injury by measurement of specific endothelial cell markers--soluble E-selectin (sES) and von Willebrand factor antigen (vWF:Ag). Thirty six severely traumatized patients were stratified according to an Injury Severity Score (ISS). Group I--patients with ISS > or = 35, Group II--patients with ISS < 35. Eleven healthy volunteers served as controls. Serum sES and plasma vWF:Ag concentrations were measured and PaO2/FiO2 ratio, Lung Injury Score (LIS) and APACHE II ratio were calculated at the admission to IC, after 24 h and on 2, 3, 5, 7, 10th day. In all investigated time periods, we observed significant increase in serum sES concentration among patients from group I, in comparison to initial value and control. On day 3, serum sES concentration was significantly increased in group I, in comparison to group II. In the first seven days, plasma vWF:Ag concentration in patients with severe multiple trauma (ISS > or = 35) was significantly elevated, in comparison to group II and control. At the admission, significant correlation between plasma vWF:Ag and ISS was found (Rs = 0.568, p < 0.001). Significant correlation between plasma vWF:Ag and serum sES concentration was also observed (Rs = 0.501, p < 0.001). In conclusion, severe trauma patients manifest endothelial cell activation/injury. Plasma vWF:Ag concentration seems to be an important, early marker of trauma severity, while serum sE-selectin level may serve as prognostic factor in immediate postinjury period course.


Subject(s)
Antigens/blood , E-Selectin/blood , Endothelium/metabolism , Multiple Trauma/immunology , Respiratory Distress Syndrome/immunology , APACHE , Adult , Biomarkers/blood , Case-Control Studies , Endothelium/injuries , Female , Humans , Injury Severity Score , Male , Middle Aged , Statistics, Nonparametric , Time Factors , von Willebrand Factor/immunology
6.
Exp Toxicol Pathol ; 52(2): 119-25, 2000 May.
Article in English | MEDLINE | ID: mdl-10965985

ABSTRACT

The activation of pulmonary alveolar macrophages (PAM's), might play an important role in severe complications of acute pancreatitis. The aim of our study was to assess the labilization of macrophage lysosomal membranes and release of lysosomal cathepsin B (CB) and N-acetyl-beta-D-hexosaminidase (NAH) into bronchoalveolar lavage fluid (BALF) during taurocholate acute pancreatitis (AP) in rats treated with PAF-antagonist--BN 52021. Total activity of CB increased by 374% after 6 h and by 237% after 12 h of AP in lysosomal enriched fraction of PAM's. Fractional free activity of CB increased to 40% after 6 h and to 38% after 12 h of AP. Free activity of CB was increased 5 fold in the supernatant of macrophage homogenate, and 10 fold in the supernatant of BALF after 6 h of AP. The values of NAH activity roughly paralleled that of CB. Treatment with BN 52021 (5 mg x kg(-1) every 6 h i.v.) partially normalized the measured parameters. Our results indicate that the PAF-antagonist BN 52021 reduced the increase of total and free activity of lysosomal hydrolases of PAM's and partly prevented the labilization of their lysosomal membranes. Therefore, an important mechanism of BN 52021 beneficial effect in pulmonary complications of acute pancreatitis could be dependent on the stabilization of PAM's lysosomes.


Subject(s)
Diterpenes , Lactones/pharmacology , Lysosomes/enzymology , Macrophages, Alveolar/ultrastructure , Pancreatitis/pathology , Platelet Activating Factor/antagonists & inhibitors , Acute Disease , Animals , Bronchoalveolar Lavage Fluid/chemistry , Bronchoalveolar Lavage Fluid/cytology , Cathepsin B/metabolism , Ginkgolides , Lymphocytes/pathology , Male , Neutrophils/pathology , Pancreatitis/chemically induced , Pancreatitis/enzymology , Rats , Rats, Wistar , Taurocholic Acid , beta-N-Acetylhexosaminidases/metabolism
7.
Z Gastroenterol ; 38(6): 469-81, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10923358

ABSTRACT

UNLABELLED: Mitogen-activated protein kinase (MAPK) family members, namely MAPK, c-Jun NH2-terminal protein kinase (JNK), and p38MAPK, have been recently reported to have opposing effects on apoptosis. AIM: To determine the activity of MAPKs and the level of Bax, Bcl-2 and p53--proteins known to be involved in the regulation of apoptosis--in pancreatic acini subjected to stressful stimuli leading to cell death. METHODS AND RESULTS: Isolated pancreatic acini were irradiated for 30 min with ultraviolet B (UV-B) or stimulated with supraphysiological concentrations of cholecystokinin (CCK). As it was assessed by means of acridine orange/ethidium bromide staining, irradiation with UV-B induced predominantly apoptosis while necrosis predominated in CCK-stimulated acini. The activity of MAPK, JNK and p38MAPK was determined by means of Western-blotting, with the use of antibodies which recognize active, dually phosphorylated enzymes. Irradiation with UV-B induced a rapid, 3-fold increase in MAPK activity. It had a maximum at 30 min and then gradually declined to reach the normal level at 120 min. Concomitantly, early activation of p38-MAPK was found at 30 min. However, unlike MAPK, p38-MAPK activity was then gradually rising to reach a maximum (5-fold increase) at 180 min. UV-B-induced activation of both kinases was not affected by the pretreatment with antioxidant--N-acetylo-L-cysteine or protein kinase C inhibitor--GF-109203X. In UV-B-irradiated cells, we did not detect any significant JNK activation as well as any significant changes in Bax, Bcl-2 and p53 levels assessed by means of Western-blotting. CONCLUSION: It seems likely that a specific interaction between MAPK and p38MAPK signaling pathway may be involved in the determination of the cell death mechanism in pancreatic acini subjected to stressful stimuli.


Subject(s)
Apoptosis/physiology , MAP Kinase Signaling System/physiology , Pancreas/cytology , Animals , Apoptosis/drug effects , Apoptosis/radiation effects , Cell Death/drug effects , Cell Death/physiology , Cell Death/radiation effects , Cholecystokinin/pharmacology , Enzyme Activation/drug effects , Enzyme Activation/radiation effects , MAP Kinase Signaling System/drug effects , MAP Kinase Signaling System/radiation effects , Male , Pancreas/drug effects , Pancreas/radiation effects , Proto-Oncogene Proteins/physiology , Proto-Oncogene Proteins c-bcl-2/physiology , Rats , Rats, Wistar , Tumor Suppressor Protein p53/physiology , Ultraviolet Rays , bcl-2-Associated X Protein
8.
Pol Arch Med Wewn ; 95(4): 369-74, 1996 Apr.
Article in Polish | MEDLINE | ID: mdl-8755844

ABSTRACT

The authors report a case of acute pancreatitis, complicated by pancreatic-peritoneal fistula and ascites in 26 year old man, with a history of excessive alcoholic intake. Biochemical investigation of ascitic and pleural fluids, which revealed markedly elevated activity of pancreatic enzymes and protein indicated their pancreatic origin. After 25 days of treatment with somatostatin and parenteral nutrition, the condition of the patient improved and he was dismissed home.


Subject(s)
Ascites/etiology , Pancreatic Fistula/diagnosis , Pancreatitis/etiology , Peritoneal Diseases/diagnosis , Adult , Humans , Male , Pancreatic Fistula/complications , Peritoneal Diseases/complications , Tomography, X-Ray Computed
9.
Pancreas ; 4(4): 436-40, 1989.
Article in English | MEDLINE | ID: mdl-2762273

ABSTRACT

It has been suggested that oxygen-derived free radicals play a decisive role in the pathogenesis of acute experimental pancreatitis in a model of edematous pancreatitis. Accordingly, allopurinol, a xanthine oxidase inhibitor, was shown to mitigate the development of nonfatal acute pancreatitis in ex vivo perfusion models using dogs. For further evaluation of allopurinol, its effect was studied in two forms of fatal necrotizing acute experimental pancreatitis: sodium taurocholate-induced pancreatitis in rats and choline-deficient ethionine-supplemented diet-induced pancreatitis in mice. Allopurinol did not affect the mortality rate, pancreatic enzyme elevation in serum and ascites, the enzyme content of the pancreas, or any parameter indicating histopathological damage in the pancreas. Although these experiments did not determine the role oxygen-derived free radicals play in the development of pancreatitis, they show, none the less, the absence of any beneficial therapeutic effect of a xanthine oxidase like allopurinol on the development of the disease once it has begun.


Subject(s)
Allopurinol/pharmacology , Pancreatitis/enzymology , Xanthine Oxidase/antagonists & inhibitors , Acute Disease , Animals , Female , Male , Mice , Pancreatitis/chemically induced , Pancreatitis/prevention & control , Rats , Taurocholic Acid/toxicity
10.
Gastroenterology ; 96(1): 193-9, 1989 Jan.
Article in English | MEDLINE | ID: mdl-2909420

ABSTRACT

Two models of severe acute pancreatitis were chosen and pancreatitis induced by sodium taurocholate and by a choline-deficient ethionine-supplemented diet, to evaluate the effectiveness of FOY-305 (camostate), a new synthetic trypsin inhibitor. Prophylactic administration of FOY-305 had a significantly favorable effect on the course of the sodium taurocholate-induced disease and on the survival rate of the treated group. A beneficial effect on the amylase and lipase content in serum and ascites was found, but no effect was observed on enzyme concentration in pancreatic tissue or on the degree of histologically detectable organ destruction. Therapeutic administration of FOY-305 had a significantly positive influence when infused directly, 5 and 30 min after the operation, whereas enzyme increase and organ destruction remained unaffected. FOY-305 showed a beneficial effect when given prophylactically or therapeutically at the beginning of the pancreatitis induced by a CDE diet, with no significant change in enzyme increase and degree of organ destruction. The favorable effect on survival time and rate in the early phase of these two severe experimental forms of pancreatitis may justify an evaluation of FOY-305 in a clinically controlled study.


Subject(s)
Gabexate/analogs & derivatives , Guanidines/therapeutic use , Pancreatitis/drug therapy , Protease Inhibitors/therapeutic use , Acute Disease , Animals , Choline Deficiency/complications , Esters , Female , Guanidines/administration & dosage , Male , Mice , Pancreatitis/chemically induced , Pancreatitis/etiology , Pancreatitis/prevention & control , Protease Inhibitors/administration & dosage , Rats , Rats, Inbred Strains , Taurocholic Acid
11.
Scand J Gastroenterol ; 23(10): 1245-9, 1988 Dec.
Article in English | MEDLINE | ID: mdl-3249921

ABSTRACT

Conscious rats were treated with a supramaximal dose of 5.10(-6)g.kg-1.h-1 of cerulein for periods of 3 and 12 h. In both groups of animals typical features of acute oedematous pancreatitis were proved by biochemical and histologic examinations. The most important finding of our study was the decrease of superoxide dismutase (SOD) activity in pancreatic tissue, accompanied by a slight increase of this scavenger enzyme in serum of rats stimulated with cerulein during 3 h. Parallelly, evident elevation of malondialdehyde (MDA) concentration in pancreatic tissue was noted. After the 12-h infusion of cerulein we were not able to detect any SOD activity in pancreatic tissue, whereas this activity appeared in ascitic fluid of tested animals. Further increase of MDA concentration in pancreatic tissue, in comparison with 3-h pancreatitis, was found. These data suggest that in 3-h and 12-h cerulein-induced pancreatitis the oxygen-derived free radicals mediate the increased lipid peroxidation in pancreatic tissue. We think that the depletion of the scavenger enzyme SOD may be responsible for such a disturbance of lipid metabolism.


Subject(s)
Ceruletide , Pancreatitis/chemically induced , Acute Disease , Animals , Ceruletide/administration & dosage , Cytosol/metabolism , Free Radicals , Male , Malondialdehyde/metabolism , Pancreatitis/metabolism , Pancreatitis/pathology , Rats , Rats, Inbred Strains , Superoxide Dismutase/metabolism
14.
Res Exp Med (Berl) ; 187(3): 211-6, 1987.
Article in English | MEDLINE | ID: mdl-3616138

ABSTRACT

Buprenorphine (15 micrograms/kg b.wt. per hour) distinctly reduced pain sensitivity in acute 3% sodium-taurocholate pancreatitis in male Wistar rats without interfering with the course of the disease. This was seen by assessment of enzyme elevation in serum and ascites and by histological evaluation of the pancreas. Buprenorphine is therefore recommended for animal experiments to study the effect of therapeutic principles in acute pancreatitis.


Subject(s)
Buprenorphine/pharmacology , Pain/drug therapy , Pancreatitis/physiopathology , Acute Disease , Animals , Male , Pain/physiopathology , Pancreatitis/chemically induced , Rats , Rats, Inbred Strains , Taurocholic Acid
15.
Digestion ; 37(3): 144-8, 1987.
Article in English | MEDLINE | ID: mdl-2443410

ABSTRACT

The serine protease inhibitor camostate (Foy-305; 200 mg/kg body weight) had been administered twice daily either subcutaneously or orally to mice for 5, 10 and 15 days. Within 5 days, pancreatic weight, concentration of trypsin, amylase and protein were significantly increased and even more increased after 10 and 15 days. This effect is less pronounced after subcutaneous administration in comparison to oral treatment.


Subject(s)
Gabexate/analogs & derivatives , Guanidines/pharmacology , Pancreas/pathology , Protease Inhibitors/pharmacology , Administration, Oral , Amylases/metabolism , Animals , Esters , Female , Guanidines/administration & dosage , Hypertrophy , Injections, Subcutaneous , Mice , Organ Size , Pancreas/drug effects , Protease Inhibitors/administration & dosage , Stimulation, Chemical , Trypsin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...